Ilc dover to unveil innovative new xtrakt™ bulk liquid dispensing system at pack expo
ILC Dover has announced that it will be conducting live demos of its new Xtrakt™ Bulk Liquid Dispensing System in...
New Nymalize Oral Solution 10 mL Unit Dose for the Treatment of Subarachnoid Hemorrhage launched by Arbor Pharma
Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, announced today that Nymalize® (nimodipine) Oral Solution will now be available in...
Saama Launches Industry Changing Life Science Analytics Cloud
Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced the launch of its Life Science...
Catalent To Acquire Cook Pharmica For $950 Million
Catalent, Inc. the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products,...
Trelegy Ellipta approved as single inhaler triple therapy for the treatment of appropriate patients with COPD in the US
GlaxoSmithKline plc and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily,...
Kaneka’s CDMO Eurogentec to build new biologics manufacturing plant in Belgium
Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility as part...
New: MACSQuant® X revolutionizes high-throughput flow cytometry
Miltenyi Biotec is launching a new era in the field of fully automated high-throughput flow cytometry analysis: Now up to...
Novartis’ Cosentyx sets new benchmark in psoriasis with robust 5-year sustained phase III efficacy & safety data
Novartis announced, first of its kind phase III data showing Cosentyx (secukinumab) delivered high and long-lasting skin clearance in patients...
Anti-Blindness Effort Pioneered by NewYork-Presbyterian/Columbia University Medical Center’s Tele-Ophthalmology Unit
Presbyterian/Columbia University Medical Center (CUMC) recently unveiled a state-of-the-art mobile testing unit in a push to reduce blindness-causing eye diseases...
Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that the United States Food and Drug Administration (“FDA”) has granted...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.